title: Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56.
abstract: Human P54 and P56 proteins are tetratricopeptide proteins that are encoded by two closely related genes, ISG54 and ISG56. These genes are induced strongly but transiently when cells are treated with interferons or double-stranded RNA or infected with a variety of viruses. We observed that, although double-stranded RNA or Sendai virus infection induced the two genes with similar kinetics, their induction kinetics in response to interferon-beta were quite different. The induction kinetics by virus infection were also different between two cell lines. Functionally the two proteins were similar. Like P56, P54 bound to the translation initiation factor eIF3 and inhibited translation. However, unlike P56, P54 bound to both the "e" and the "c" subunits of eIF3. Consequently, P54 inhibited two functions of eIF3. Like P56, it inhibited the ability of eIF3 to stabilize the eIF2 x GTP x Met-tRNA(i) ternary complex. But in addition, it also inhibited the formation of the 48 S pre-initiation complex between the 40 S ribosomal subunit and the 20 S complex composed of eIF3, ternary complex, eIF4F, and mRNA. Thus, although similar in structure, the human P54 and P56 proteins are induced differently and function differently.
authors.affiliation: Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
authors.forename: Fulvia
authors.initials: F
authors.lastname: Terenzi
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Hui
authors.forename: William C
authors.initials: WC
authors.lastname: Merrick
authors.forename: Ganes C
authors.initials: GC
authors.lastname: Sen
mesh_terms: D048868:Adaptor Proteins, Signal Transducing; D051017:Apoptosis Regulatory Proteins; D002478:Cells, Cultured / Q000378:metabolism / Q000821:virology; D039621:Eukaryotic Initiation Factor-3 / Q000235:genetics / Q000378:metabolism*; D005354:Fibrosarcoma / Q000188:drug therapy / Q000378:metabolism / Q000821:virology; D006801:Humans; D047468:Immunoprecipitation; D016899:Interferon-beta / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects / Q000378:metabolism / Q000821:virology; D008954:Models, Biological; D010957:Plasmids; D014176:Protein Biosynthesis; D011506:Proteins / Q000378:metabolism*; D012330:RNA, Double-Stranded / Q000502:physiology; D012358:RNA, Transfer, Met / Q000378:metabolism; D016601:RNA-Binding Proteins; D011994:Recombinant Proteins; D012260:Ribonucleases; D012270:Ribosomes / Q000378:metabolism; D029082:Sendai virus / Q000502:physiology; D014157:Transcription Factors / Q000096:biosynthesis*; D014162:Transfection
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D051017:Apoptosis Regulatory Proteins; D039621:Eukaryotic Initiation Factor-3; C484290:IFIT1 protein, human; C484289:IFIT2 protein, human; C112736:Met-tRNA(i)(Met); D011506:Proteins; D012330:RNA, Double-Stranded; D012358:RNA, Transfer, Met; D016601:RNA-Binding Proteins; D011994:Recombinant Proteins; D014157:Transcription Factors; D016899:Interferon-beta; D012260:Ribonucleases